Literature DB >> 11903990

Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand?

Petchawan Pungrassami1, Søren P Johnsen, Virasakdi Chongsuvivatwong, Jørn Olsen.   

Abstract

OBJECTIVE: To validate the practice of directly observed treatment (DOT) and evaluate its effect on treatment outcomes.
METHODS: This follow-up study conducted in 24 districts in southern Thailand included 411 new, smear-positive, pulmonary tuberculosis (TB) patients who started treatment between February and September 1999. Patients and/or their observers were interviewed about their actual DOT practice during the first 2 months of treatment. Treatment outcomes were evaluated at the end of the second month and at the end of treatment.
RESULTS: Of 411 patients, 379 were assigned to DOT but only 68 practised strict DOT for every dose during the first 2 months. Adjusted odds ratios (ORs) for 'no sputum conversion' and 'unsuccessful treatment' were 1.1 (95% CI 0.6-2.1) and 1.3 (95% CI 0.6-2.8), respectively, for those who practised strict DOT vs. the rest.
CONCLUSIONS: Actual practice of DOT was quite different from what was intended at the assignment. Practice of strict DOT during the first 2 months was not associated with sputum conversion or treatment success in this study area.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11903990     DOI: 10.1046/j.1365-3156.2002.00849.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  15 in total

1.  Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.

Authors:  Patrick K Moonan; Stephen E Weis
Journal:  Clin Infect Dis       Date:  2013-06-27       Impact factor: 9.079

Review 2.  Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an update.

Authors:  April C Pettit; Bryan E Shepherd; Timothy R Sterling
Journal:  Curr Opin HIV AIDS       Date:  2018-11       Impact factor: 4.283

3.  Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program.

Authors:  Felix R Kayigamba; Mirjam I Bakker; Veronicah Mugisha; Michel Gasana; Maarten F Schim van der Loeff
Journal:  BMC Res Notes       Date:  2012-07-16

Review 4.  Directly observed therapy for treating tuberculosis.

Authors:  Jamlick Karumbi; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

5.  Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness.

Authors:  Cameron M Wright; Lenna Westerkamp; Sarah Korver; Claudia C Dobler
Journal:  BMC Infect Dis       Date:  2015-05-08       Impact factor: 3.090

6.  A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

7.  Directly observed therapy and improved tuberculosis treatment outcomes in Thailand.

Authors:  Amornrat Anuwatnonthakate; Pranom Limsomboon; Sriprapa Nateniyom; Wanpen Wattanaamornkiat; Sittijate Komsakorn; Saiyud Moolphate; Navarat Chiengsorn; Samroui Kaewsa-Ard; Potjaman Sombat; Umaporn Siangphoe; Philip A Mock; Jay K Varma
Journal:  PLoS One       Date:  2008-08-28       Impact factor: 3.240

8.  Treatment supporters and their impact on treatment outcomes in routine tuberculosis program conditions in rawalpindi district, pakistan.

Authors:  Munawar Hussain Soomro; Ejaz Qadeer; Muhammad Amir Khan; Odd Morkve
Journal:  Tanaffos       Date:  2012

9.  Thai district Leaders' perceptions of managing the direct observation treatment program in Trang Province, Thailand.

Authors:  Jiraporn Choowong; Per Tillgren; Maja Söderbäck
Journal:  BMC Public Health       Date:  2016-07-28       Impact factor: 3.295

10.  Addressing tuberculosis control in fragile states: Urban DOTS experience in Kabul, Afghanistan, 2009-2015.

Authors:  G Qader; A Hamim; M Sayedi; M Rashidi; L Manzoor; M K Seddiq; N Ikram; P G Suarez
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.